Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gliosarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01110876
What this trial is testing

Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma Multiforme
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT00936052
What this trial is testing

Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomasGliosarcoma
Neurological Surgery, P.C. 20
Testing effectiveness (Phase 2)Study completedNCT01113398
What this trial is testing

AMG 102 and Avastin for Recurrent Malignant Glioma

Who this might be right for
Glioblastoma MultiformeGliosarcoma
Katy Peters 36
Early research (Phase 1)Study completedNCT00002572
What this trial is testing

Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
University of Colorado, Denver 10
Testing effectiveness (Phase 2)Study completedNCT01514201
What this trial is testing

Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas

Who this might be right for
Anaplastic AstrocytomaBrain Stem GliomaChildhood Mixed Glioma+10 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)UnknownNCT00114309
What this trial is testing

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+3 more
TransMolecular 66
Early research (Phase 1)Study completedNCT00017264
What this trial is testing

Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00079092
What this trial is testing

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Wake Forest University Health Sciences 18
Not applicableStudy completedNCT01004887
What this trial is testing

Study of Tissue and Blood Samples From Patients With High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 631
Not applicableStudy completedNCT00253487
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Children's Hospital Medical Center, Cincinnati
Testing effectiveness (Phase 2)Study completedNCT00331526
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Hoag Memorial Hospital Presbyterian 83
Testing effectiveness (Phase 2)Study completedNCT01856933
What this trial is testing

BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)

Who this might be right for
GBMGlioblastoma MultiformeGliosarcoma
Heinrich Elinzano, MD 6
Early research (Phase 1)Study completedNCT00613054
What this trial is testing

Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma

Who this might be right for
GlioblastomaGliosarcoma
Annick Desjardins 27
Testing effectiveness (Phase 2)Study completedNCT00379080
What this trial is testing

Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Brain TumorAdult Giant Cell GlioblastomaAdult Glioblastoma+2 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00006388
What this trial is testing

Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 77
Early research (Phase 1)Looking for participantsNCT04991870
What this trial is testing

Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM

Who this might be right for
Recurrent GliosarcomaRecurrent Supratentorial GlioblastomaSupratentorial Gliosarcoma
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00086879
What this trial is testing

Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 110
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Early research (Phase 1)Study completedNCT00004262
What this trial is testing

Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Ended earlyNCT01582152
What this trial is testing

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma

Who this might be right for
Brain NeoplasmsCentral Nervous System Neoplasms
M.D. Anderson Cancer Center 12
Next Page